You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for NDC 42543-0962


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 42543-0962

Drug Name NDC Price/Unit ($) Unit Date
CINACALCET HCL 60 MG TABLET 42543-0962-04 0.59437 EACH 2024-12-18
CINACALCET HCL 60 MG TABLET 42543-0962-04 0.52367 EACH 2024-11-20
CINACALCET HCL 60 MG TABLET 42543-0962-04 0.70492 EACH 2024-10-23
CINACALCET HCL 60 MG TABLET 42543-0962-04 0.66500 EACH 2024-09-18
CINACALCET HCL 60 MG TABLET 42543-0962-04 0.55430 EACH 2024-08-21
CINACALCET HCL 60 MG TABLET 42543-0962-04 0.52666 EACH 2024-07-17
CINACALCET HCL 60 MG TABLET 42543-0962-04 0.61137 EACH 2024-06-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 42543-0962

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
CINACALCET HCL 60MG TAB Golden State Medical Supply, Inc. 42543-0962-04 30 316.19 10.53967 2023-06-15 - 2028-06-14 FSS
CINACALCET HCL 60MG TAB Golden State Medical Supply, Inc. 42543-0962-04 30 335.66 11.18867 2023-06-23 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

42543-0962 Market Analysis and Financial Projection

Market Analysis and Price Projections for NDC 42543-0962: Cinacalcet

Introduction to NDC 42543-0962

NDC 42543-0962 corresponds to Cinacalcet, a medication manufactured by Strides Pharma Inc. Cinacalcet is used to treat secondary hyperparathyroidism in patients with chronic kidney disease on dialysis and hypercalcemia in patients with parathyroid carcinoma[5].

Understanding the NDC Directory

The National Drug Code (NDC) Directory, maintained by the FDA, is a crucial resource for identifying and tracking pharmaceutical products. The new NDC Directory includes all electronically listed drugs in their final marketed format, including over-the-counter drugs, and provides additional data elements such as the Drug Enforcement Administration schedule and pharmacological class[1].

Market Size and Growth Projections

The pharmaceutical market, particularly the segment involving generic and branded drugs like Cinacalcet, is expected to grow significantly. The US pharmaceutical market is projected to increase from $846.72 billion in 2022 to $1.28 trillion by 2030, with a compound annual growth rate (CAGR) of 5.36%. This growth is driven by factors such as rising pharmaceutical production capacity, greater approvals of generic drugs, and escalating R&D investments[2].

Pricing Mechanisms

Average Manufacturer Price (AMP) and Unit Rebate Amount (URA)

For drugs covered under the Medicaid Drug Rebate Program, the 340B ceiling price is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure. This price is then adjusted by the package size and case pack size to determine the final ceiling price.

340B Ceiling Price = (AMP - URA) × Package Size × Case Pack Size

For example, if the AMP for Cinacalcet is $50 per unit, the URA is $10 per unit, the package size is 30 units, and the case pack size is 5 packages:

340B Ceiling Price = (50 - 10) × 30 × 5 = $6,000

This calculation provides a baseline for the ceiling price, but actual market prices can vary based on various factors[2].

Factors Influencing Price Projections

Historical Pricing Data

Reviewing historical pricing data from the NDC Directory and other sources can provide insights into price trends and potential future adjustments. For Cinacalcet, analyzing past price changes can help predict future pricing strategies.

Regulatory Changes

Changes in regulatory policies, such as updates to the Medicaid Drug Rebate Program or new FDA guidelines, can significantly impact pricing. For instance, any changes in rebate structures or pricing formulas can affect the final cost of the drug[2].

Market Demand and Competition

The demand for Cinacalcet and the level of competition in the market can influence pricing strategies. If there are multiple generic versions of Cinacalcet available, competition could drive prices down. Conversely, if Cinacalcet remains a unique treatment option, prices might remain stable or increase[2].

Technological Advancements

The adoption of AI and other technological advancements can reduce development and manufacturing costs, potentially leading to lower prices. However, for a drug like Cinacalcet, which is already in the market, the impact of these advancements might be more on the production efficiency rather than the price[2].

International Price Comparisons

Prescription drug prices in the U.S. are often significantly higher than in other high-income countries. For example, U.S. prices for brand-name drugs are approximately 422% of prices in comparison countries. This disparity could influence pricing strategies if international reference pricing becomes more prevalent[4].

Biopharma and Biotech Industry Trends

The biopharma and biotech industries are experiencing rapid growth due to advancements in technological capabilities, evolving regulatory frameworks, and a shift towards patient-centered care. While Cinacalcet is not a biopharmaceutical, the overall trends in these industries can influence the broader pharmaceutical market. Innovations in clinical trial designs, precision medicine, and AI/ML technologies are expected to shape the future of medicine, potentially impacting pricing and market dynamics[3].

Example Price Projection for Cinacalcet

Assuming Cinacalcet has a moderate demand and faces some competition from other treatments or generic versions:

  • AMP: $50 per unit
  • URA: $10 per unit
  • Package Size: 30 units
  • Case Pack Size: 5 packages

Using the 340B ceiling price formula:

340B Ceiling Price = (50 - 10) × 30 × 5 = $6,000

If the market demand remains stable and there is moderate competition, the price might remain around this calculated ceiling price. However, if demand increases or competition decreases, the price could rise. Conversely, if demand drops or competition increases, the price might decrease[2].

Key Takeaways

  • Market Growth: The US pharmaceutical market is expected to grow significantly, driven by increased production capacity and R&D investments.
  • Pricing Mechanisms: The 340B ceiling price calculation is crucial for determining prices for drugs covered under the Medicaid Drug Rebate Program.
  • Regulatory and Market Factors: Historical pricing data, regulatory changes, market demand, and competition are key factors influencing price projections.
  • International Comparisons: U.S. drug prices are generally higher than in other countries, which could impact pricing strategies if international reference pricing becomes more common.
  • Technological Advancements: Innovations in biopharma and biotech can influence the broader pharmaceutical market, including production efficiency and pricing.

FAQs

Q: What is the NDC Directory, and how does it help in market analysis? A: The NDC Directory is a resource maintained by the FDA that lists unique National Drug Codes for marketed products. It helps in market analysis by providing searchable features and data elements such as the Drug Enforcement Administration schedule and pharmacological class.

Q: How is the 340B ceiling price calculated for a drug like Cinacalcet? A: The 340B ceiling price is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure, then adjusting by the package size and case pack size.

Q: What factors influence price projections for pharmaceuticals? A: Historical pricing data, regulatory changes, market demand, competition, and technological advancements are key factors influencing price projections.

Q: How do international price comparisons affect U.S. drug prices? A: U.S. drug prices are often significantly higher than in other high-income countries. International reference pricing could influence U.S. pricing strategies if adopted more widely.

Q: What role do technological advancements play in pharmaceutical pricing? A: Technological advancements, such as AI and other innovations, can reduce development and manufacturing costs, potentially leading to lower prices or increased production efficiency.

Sources

  1. YouTube: NDC Directory (March 2015) - YouTube
  2. Drug Patent Watch: Latest pharmaceutical drug prices and trends for NDC 00093-7662
  3. TFS CRO: 5 Predictions for the Biopharma and Biotech Industries in 2025
  4. ASPE: International Prescription Drug Price Comparisons: Estimates Using IQVIA MIDAS Data
  5. FindACode: Strides Pharma Inc. - List of Drugs - NDC Labeler/Manufacturer

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.